Literature DB >> 22402436

Foxp3+ cells control Th2 responses in a murine model of atopic dermatitis.

Nanna Fyhrquist1, Sari Lehtimäki, Katharina Lahl, Terhi Savinko, Anna-Mari Lappeteläinen, Tim Sparwasser, Henrik Wolff, Antti Lauerma, Harri Alenius.   

Abstract

The role of Foxp3+ regulatory T (Treg) cells in atopic dermatitis (AD) is still unclear. In a murine AD model, the number of Foxp3+ cells increased in the allergen-exposed skin area and in the secondary lymphoid organs. Both Foxp3+ and Foxp3- IL-10+ T cells accumulated at the site of allergen exposure, and CD103+ effector/memory Foxp3+ Treg cells expanded gradually in the lymph nodes throughout the sensitization protocol. The depletion of Foxp3+ Treg cells led to significantly exacerbated skin inflammation, including increased recruitment of inflammatory cells and expression of T helper type 2 cytokines, as well as elevated serum IgE levels. The effect of depleting Treg cells during epicutaneous sensitization was mirrored off by a stronger inflammatory response also in the lungs following airway challenge. Thus, Treg cells have an important role in controlling AD-like inflammation and the transfer of allergic skin inflammation to the lungs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22402436     DOI: 10.1038/jid.2012.40

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  27 in total

1.  Loss of c-REL but not NF-κB2 prevents autoimmune disease driven by FasL mutation.

Authors:  L A O'Reilly; P Hughes; A Lin; P Waring; U Siebenlist; R Jain; D H D Gray; S Gerondakis; A Strasser
Journal:  Cell Death Differ       Date:  2014-10-31       Impact factor: 15.828

2.  Dermatological therapy by topical application of non-pathogenic bacteria.

Authors:  Teruaki Nakatsuji; Richard L Gallo
Journal:  J Invest Dermatol       Date:  2014-01       Impact factor: 8.551

Review 3.  T Regulatory Cell Biology in Health and Disease.

Authors:  Fayhan J Alroqi; Talal A Chatila
Journal:  Curr Allergy Asthma Rep       Date:  2016-04       Impact factor: 4.806

4.  Defective natural killer cell activity in a mouse model of eczema herpeticum.

Authors:  Yuko Kawakami; Tomoaki Ando; Jong-Rok Lee; Gisen Kim; Yu Kawakami; Tae Nakasaki; Manando Nakasaki; Kenji Matsumoto; Youn Soo Choi; Toshiaki Kawakami
Journal:  J Allergy Clin Immunol       Date:  2016-07-29       Impact factor: 10.793

5.  Superior Suppressive Capacity of Skin Tregs Compared with Lung Tregs in a Model of Epicutaneous Priming.

Authors:  Subhashree Mahapatra; Melanie Albrecht; Abdul M Baru; Tim Sparwasser; Christina Herrick; Anna M Dittrich
Journal:  J Invest Dermatol       Date:  2015-05-22       Impact factor: 8.551

6.  Distinct cutaneous bacterial assemblages in a sampling of South American Amerindians and US residents.

Authors:  Martin J Blaser; Maria G Dominguez-Bello; Monica Contreras; Magda Magris; Glida Hidalgo; Isidoro Estrada; Zhan Gao; Jose C Clemente; Elizabeth K Costello; Rob Knight
Journal:  ISME J       Date:  2012-08-16       Impact factor: 10.302

7.  Impact of loss of NF-κB1, NF-κB2 or c-REL on SLE-like autoimmune disease and lymphadenopathy in Fas(lpr/lpr) mutant mice.

Authors:  J T Low; P Hughes; A Lin; U Siebenlist; R Jain; K Yaprianto; D H D Gray; S Gerondakis; A Strasser; L A O'Reilly
Journal:  Immunol Cell Biol       Date:  2015-06-18       Impact factor: 5.126

8.  Complex 2B4 regulation of mast cells and eosinophils in murine allergic inflammation.

Authors:  Moran Elishmereni; Nanna Fyhrquist; Roopesh Singh Gangwar; Sari Lehtimäki; Harri Alenius; Francesca Levi-Schaffer
Journal:  J Invest Dermatol       Date:  2014-07-07       Impact factor: 8.551

9.  SHARPIN controls the development of regulatory T cells.

Authors:  Vanessa Redecke; Vandana Chaturvedi; Jeeba Kuriakose; Hans Häcker
Journal:  Immunology       Date:  2016-04-12       Impact factor: 7.397

Review 10.  Which Way Do We Go? Complex Interactions in Atopic Dermatitis Pathogenesis.

Authors:  Garrett J Patrick; Nathan K Archer; Lloyd S Miller
Journal:  J Invest Dermatol       Date:  2020-09-15       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.